-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623. Lymphoma: Chemotherapy, excluding Pre-Clinical Models: Poster II

Lymphoma: Chemotherapy, excluding Pre-Clinical Models Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Mary Gleeson1*, Eliza A Hawkes1*, David Cunningham1*, Nick Chadwick2*, Nick Counsell2*, Anthony Lawrie2*, Andrew Jack3*, Paul Smith2*, Paul Mouncey2*, Christopher Pocock4, Kirit Ardeshna5,6*, John Radford7*, Andrew McMillan8*, John Davies9*, Deborah Turner10*, Anton Kruger11*, Peter W.M. Johnson, FRCP12*, Joanna Gambell2* and David Linch5*

1The Royal Marsden Hospital, London and Surrey, United Kingdom
2Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom
3HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
4East Kent Hospitals, Canterbury, United Kingdom
5University College London, London, United Kingdom
6Mount Vernon Cancer Centre, Northwood, United Kingdom
7The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
8Nottingham City Hospital, Nottingham, United Kingdom
9Western General Hospital, Edinburgh, United Kingdom
10Torbay Hospital, Torquay, United Kingdom
11Royal Cornwall Hospital, Truro, United Kingdom
12Cancer Research UK Centre, Southampton, United Kingdom

Tongyu Lin*, He Huang*, Xueying Li*, Chengcheng Guo*, Huangming Hong*, Xiaohong Fu*, Xiaoting Lin*, Xiaojie Fang*, Zhao Wang* and Zhongjun Xia, MD

Sun Yat-sen University Cancer Center, Guangzhou, China

Jacob D Soumerai, MD1, Andrew D Zelenetz, MD, PhD1, Craig H Moskowitz, MD2, Anas Younes, MD1, Maria Lia Palomba, MD1, Paul A Hamlin Jr., MD1, Ariela Noy, MD1, Steven M Horwitz, MD1, Matthew J. Matasar, MD, MS2, Alison J Moskowitz, MD1, Carol S Portlock, MD1, David J Straus, MD1, Alice Chen, MD3*, Richard F Little, MD, MPH3, Fallon France4*, Juho Whang4*, Nishant Mishra4*, Christine Jarjies4* and John F Gerecitano, MD, PhD1

1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY
3Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD
4Memorial Sloan Kettering Cancer Center, New York, NY

Jaleh Fallah, MD1, Anthony G Thomas, DO, FACP1,2* and Adam J Olszewski, MD1,2

1Department of Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI
2Division of Hematology-Oncology, Alpert Medical School of Brown University, Providence, RI

Adam M. Petrich, MD1, Leo I. Gordon, MD2, Jeffrey R. Infante, MD3*, Sumit Madan, MD4*, Francis J. Giles, MD5*, Halla S. Nimeiri, MBBS1*, Jason B. Kaplan, MD1*, Kate Stumpo6*, Bin Zhang, ScD7*, Stephanie Faucette, PharmD, PhD8*, Yaping Shou, MD, PhD9* and Kent C. Shih, MD10*

1NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University, Chicago, IL
2Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
3Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
4Hematology-Oncology, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX
5NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago
6Clinical Operations Early Development, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
7Global Statistics, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
8Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
9Oncology Clinical Research, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
10Neuro-Oncology Program, Sarah Cannon Research Institute, Nashville, TN

Jakub Svoboda, MD1, Lauren E. Strelec, BA1*, Sunita Dwivedy Nasta, MD1*, Daniel J. Landsburg, MD1, Anthony R. Mato, MD2*, Barbara Pro3, Stefan Klaus Barta, MD, MRCP, MS4, Nirav N. Shah, MD1, Sarah Jordan Nagle, MD1*, Elise A. Chong, MD1, Ellen Napier, NP1*, Samantha Garrett1* and Stephen J. Schuster, MD1

1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Center for Chronic Lymphocytic Leukemia, University of Pennsylvania, Philadelphia, PA
3Thomas Jefferson University, Philadelphia, PA
4Fox Chase Cancer Center, Philadelphia, PA

Kristin C. Marr, MD1*, Joseph M. Connors, MD2, Karen J. Goddard, MD3*, Kerry J. Savage, MD MSc2 and Rebecca J. Deyell, MD1*

1Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, British Columbia Children’s Hospital, University of British Columbia, Vancouver, BC, Canada, Vancouver, BC, Canada
2British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
3British Columbia Cancer Agency, Department of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada, Vancouver, BC, Canada

Daniel J. Landsburg, MD1, Marissa K. Falkiewicz2*, Jennifer J.D. Morrissette, PhD3*, April M. Schrank-Hacker4*, Sunita Dwivedy Nasta, MD5, Jakub Svoboda, MD6, Stephen J. Schuster, MD7, Anthony R. Mato, MD8*, Benjamin A. Chu9*, Yanming Zhang, MD10, Amir Behdad, MD10* and Adam M. Petrich, MD11

1Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Robert Wood Johnson Medical School, New Brunswick, NJ
3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
4Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
6Lymphoma Program, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
7Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
8Center for Chronic Lymphocytic Leukemia, University of Pennsylvania, Philadelphia, PA
9Feinberg School of Medicine, Northwestern University, Chicago, IL
10Department of Pathology, Northwestern University, Chicago, IL
11Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL

Simonetta Viviani, MD1*, Alberto Mussetti, MD1*, Oreste Di Bartolo, MD2*, Antonello Cabras, MD3*, Pinuccia Valagussa, Statistician4*, Gianni Bonadonna, MD4*, Alessandro M. Gianni, MD5 and Paolo Corradini, MD6

1Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
2Chair of Hematology, Università degli Studi, Catania, Italy
3Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
4Fondazione Michelangelo, Milan, Italy
5Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
6Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS Istituto Nazionale Tumori and University of Milano, Milan, Italy

Eldad J Dann, MD1,2, Vered Heffes, BsC1*, Tatiana Mashiach, MSc2*, Noam Benyamini, MD3*, Irit Avivi, MD4* and Netanel A Horowitz, MD1,2*

1Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
2Rambam Health Care Campus, Haifa, Israel
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
4R, Haifa, Israel

Pau Abrisqueta, MD1*, Graham W Slack, MD1*, David W Scott, MBChB, PhD1, Randy D. Gascoyne2, Joseph M. Connors, MD3, Laurie H. Sehn1, Kerry J. Savage, MD MSc3 and Diego Villa, MD, MPH4

1Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
2British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
3British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
4BC Cancer Agency and University of British Columbia, Centre for Lymphoid Cancer, Vancouver, BC, Canada

Preetesh Jain, MBBS, MD, DM, PhD1*, Keyur P. Patel, MD, PhD2*, Andrew Futreal, PhD3*, Curtis Gumbs3*, Shimin Hu, PhD, MD4*, Carlos Bueso Ramos, MD5*, Michael Wang, MD6, Jorge Romaguera5*, Luis E. Fayad, MD7, Robert Z. Orlowski, Ph.D., M.D.7, Jeffrey Medeiros5* and Nathan Fowler, MD8

1Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4University of Texas MD Anderson Cancer Center PTH Program, Houston, TX
5University of Texas, The MD Anderson Cancer Center, Houston
6Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Sarah Jordan Nagle, MD1*, Nirav N. Shah, MD1, Alex Ganetsky, PharmD, BCOP2*, Daniel J. Landsburg, MD1, Sunita Dwivedy Nasta, MD1, Anthony Mato, MD1*, Stephen J. Schuster, MD1, Donald Edward Tsai, MD, PhD1 and Jakub Svoboda, MD3

1Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA
3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Mitchell R. Smith, MD, PhD1, Hailun Li, PhD2*, Fangxin Hong, Ph.D.3, Leo I. Gordon, MD4, Randy D. Gascoyne5, Elisabeth Paietta, MD6, Ranjana H Advani, MD7, Andres Forrero-Torres8*, Sandra J Horning, MD9 and Brad S. Kahl, MD10

1Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2ECOG-ACRIN, Boston, MA
3Harvard School of Public Health, Boston, MA
4Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
5Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
6Cancer Center, Montefiore Medical Center North Division, Bronx, NY
7Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, CA
8University of Alabama-Birmingham, Birmingham, AL
9Genentech, Inc., South San Francisco, CA
10Department of Medicine-Hematology/Oncology, University of Wisconsin, Madison, WI

Masahito Tokunaga, M.D.1*, Kentaro Yonekura2*, Daisuke Nakamura3*, Kouichi Haraguchi4*, Tomohisa Tabuchi5*, Nobuaki Nakano1*, Ayumu Kubota, M.D.1*, Shogo Takeuchi, M.D.1*, Yoshifusa Takatsuka1*, Makoto Yoshimitsu5, Satoshi Fujino5*, Maiko Hayashida5*, Kenichi Maekawa5*, Akihiko Arai4*, Yuhei Kamata5*, Hirosaka Inoue5*, Satsuki Owatari4*, Maki Otsuka4*, Shuichi Hanada4, Tadashi Matsumoto3* and Atae Utsunomiya, M.D., Ph.D.1

1Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
2Department of Dermatology, Imamura Bun-in Hospital, Kagoshima, Japan
3Department of Hematology, Imamura Hospital, Kagoshima, Japan
4Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
5Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan

Anita K. Gandhi, PhD1*, Ribrag Vincent, MD2*, Cecilia Carpio, MD3*, Anne-Marie Stoppa, MD4, Mecide Meric Gharibo, MD5*, Sylvia Damian, MD6*, Drew W Rasco, MD7*, Loïc Ysebaert, MD PhD8*, Raúl Cordoba, MD9*, Armando Santoro, MD10*, William J Edenfield, MD11*, Antonio Pinto12*, José Antonio López-Martín, MD13*, Juan Manuel Sancho, MD, PhD14*, Carlos Panizo, PhD15*, Xin Wei1*, Patrick Hagner, PhD1*, Michelle Waldman, MS1*, Kristen Hege16, Rajesh Chopra, MBBS, PhD1 and Michael Pourdehnad, MD16*

1Celgene Corporation, Summit, NJ
2Service d'Hématologie, Institut Gustave Roussy, Villejuif, France
3Hospital Vall d'Hebron, Barcelona, Spain
4Institut Paoli Calmettes, Marseille, France
5Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
6Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
7START, San Antonio, TX
8Département d'Hématologie, IUCT-Oncopole, Toulouse, France
9Hospital Fundación Jiménez-Díaz, Madrid, Spain
10Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy
11Cancer Centers Of The Carolinas, Greenville, SC
12Fondazione ‘G.Pascale’, IRCCS, Istituto Nazionale Tumori, Naples, Italy
1312 de Octubre University Hospital, Madrid, Spain
14Clinica Universidad de Navarra, Pamplona, Spain
15Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
16Celgene Corporation, San Francisco, CA

Michelle A. Fanale, MD1, Zhiqiang Wang, PhD1*, Wencai Ma, PhD1*, Yasuhiro Oki, MD1, Fredrick B. Hagemeister, MD1, Luis E. Fayad, MD1, Nathan Fowler, MD1, Jorge E. Romaguera, MD1, Nina Shah, MD2, Hubert H Chuang, MD, PhD3*, Feng Lei, MS4*, Sandra B. Horowitz, PharmD5*, Dai Chihara, MD, PhD1, Emily Wesson, APN1*, Toni Y Hutto, BS1*, Charnelle Ruben, BS1*, Felipe Samaniego, MD1, Tariq Muzzafar, MD6, Richard Piekarz, PhD, MD7* and R Eric Davis, MD1*

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Cancer Therapeutics Evaluation Program, National Institute of Health, Bethesda, MD

Nathan Fowler, MD1, Thomas E Boyd, MD2*, Jeff P. Sharman, MD3, Sonali M. Smith, MD4, Fong Clow, ScD5, Alvina D. Chu, MD5* and Ranjana H Advani, MD6

1Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
2Oncology/Hematology, Yakima Valley Memorial Hospital/North Star Lodge Cancer Center, Yakima, WA
3Willamette Valley Cancer Institute, Springfield, OR
4University of Chicago, Chicago, IL
5Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
6Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, CA

Pieternella J Lugtenburg, MD, PhD1, Josée M Zijlstra, MD, PhD2*, Jeanette K Doorduijn, MD, PhD1, Lara H Böhmer, MD3*, Marinus van Marwijk Kooy, MD, PhD4*, Mels Hoogendoorn, MD, PhD5*, Henriette W Berenschot, MD6*, Aart Beeker, MD7, Fransje Valster, MD8*, Harry C. Schouten9, Marleen Luten, MSc10*, Henk Hofwegen10*, Dana A Chitu, PhD11*, Rolf E Brouwer, MD, PhD12 and Gustaaf W van Imhoff, MD, PhD13

1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
2Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, Netherlands
3Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
4Department of Internal Medicine, Isala Clinic, Zwolle, Netherlands
5Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands
6Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
7Department of Internal Medicine, Spaarne Hospital, Hoofddorp, Netherlands
8Department of Internal Medicine, Bravis Hospital, Bergen op Zoom, Netherlands
9Department of Internal Medicine - Hematology, Maastricht University Medical Center, Maastricht, Netherlands
10HOVON Data Center, Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands
11HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands
12Department of Internal Medicine, Reinier de Graaf Group, Delft, Netherlands
13Department of Hematology, University Hospital Groningen, Groningen, Netherlands

Olga A. Gavrilina, MD1*, Eugene E. Zvonkov, MD, PhD2*, Elena N. Parovichnikova, MD, PhD2*, Vera V. Troitskaya, MD, PhD2*, Nelly G. Gabeeva, PhD3*, Andrey V. Gubkin4*, Larisa A. Kuzmina, MD, PhD5*, Valery A. Lapin6*, Inessa Yu. Toropova6*, Vitalii S. Kanin7* and Valeri G. Savchenko, MD, PhD, Prof.2

1National Research Center For Hematology, Moscow, Russia
2National Research Center for Hematology, Moscow, Russia
3Department Chemotherapy of lymphomas, National Research Center for Hematology, Moscow, Russia
4Central Clinical Hospital №2, Moscow, Russia
5Department of BMT, National Research Center for Hematology, Moscow, Russia
6Yaroslavl Regional Hospital, Yaroslavl, Russia
7Regional Clinical Center of Oncology, Khabarovsk, Russia

Wei-Li Ma, MD

Oncology, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan

Antonio Branca, MD1*, Ilaria Gianesello, MD2*, Luca Brugnaro, RN3*, Tamara Berno, MD2*, Silvia Imbergamo, MD2*, Federica Lessi, MD2*, Kety Sammartin, MD2*, Fabrizio Vianello, MD2*, Fausto Adami, MD2*, Gianni Binotto2*, Carmela Gurrieri, MD2*, Livio Trentin, MD2, Carlo Visco, MD4*, Renato Zambello2*, Francesco Piazza, MD5 and Gianpietro Semenzato2*

1Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy
2Department of Medicine, Hematology and Clinical Immunology Section, University of Padova, Padova, Italy
3Padova University Hospital, Padova, Italy
4Department of Hematology and Cell Therapy, Ospedale San Bortolo, Vicenza, Italy
5Department of Medicine, Hematology and Clinical Immunology Section, University of Padova and Venetian Institute of Molecular Medicine, Padova, Italy

Binod Dhakal, MD1, Sridevi Ramalingam, MD2*, Jamie Shuff, MD3*, Narendranath Epperla, MD4, Lisa Rein, MS5*, Anjishnu Banerjee, PhD6*, Malika Siker, MD7*, Paul R. Hosking, MD5*, Parameswaran Hari, MD, MRCP, MS5, Anita D'Souza, MBBS, MD8, Ehab Atallah, MD9, Beth Erisckson, MD7*, Timothy S. Fenske, MD4 and Mehdi Hamadani, M.D.10*

1Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
2Medical College of Wisconsin, milwaukee, WI
3Radiation Oncology Associates, Reno, NV
4Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
5Medical College of Wisconsin, Milwaukee, WI
6Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
7Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
8Froedtert Memorial Lutheran Hospital, Milwaukee, WI
9Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
10Dept. of Medicine, Medical College of Wisconsin, Milwaukee, WI

Lalita Norasetthada, MD1, Weerasak Nawarawong, MD2, Arnuparp Lekhakula, MD, MS3*, Jakrawadee Julamanee, MD3*, Chittima Sirijerachai, MD4*, Kanchana Chansung, MD4*, Kitsada Wudhikarn, MD5*, Udomsak Bunworasate, MD6*, Noppadol Siritanaratanakul, MD7, Archrob Khuhapinant, MD, PhD7, Tontanai Numbenjapon, MD8*, Kannadit Prayongratana, MD8*, Tawatchai Suwanban, MD9*, Suporn Chuncharunee, MD10, Pimjai Niparuck, MD10*, Somchai Wongkhantee, MD11*, Peerapon Wong, MD12*, Nisa Makruasi, MD13*, Nonglak Kanitsap, MD14* and Tanin Intragumtornchai, MD, MSc5

1Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand
2Department of Medicine, Chiang Mai University, Chiang Mai, Thailand
3Department of Internal Medicine, Prince of Songkla University, Songkla, Thailand
4Department of Medicine, Khon Kaen University, Khon Kaen, Thailand
5Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
6Department of Medicine, Chulalongkorn University, Bangkok, Thailand
7Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
8Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
9Department of Medicine, Rajavithi Hospital, Bangkok, Thailand
10Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
11Department of Medicine, Khonkaen Regional Hospital, Khon Kaen, Thailand
12Department of Medicine, Naresuan University, Phitsanulok, Thailand
13Department of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand
14Department of Medicine, Thammasat University, Bangkok, Thailand

Norina Tanaka, MD, PhD*, Yoichi Imai, MD, PhD, Aya Watanabe, MD*, Kenjiro Mitsuhashi, MD, PhD*, Kentaro Yoshinaga, MD, PhD*, Masayuki Shiseki, MD, PhD, Naoki Mori, MD, PhD* and Junji Tanaka, M.D., Ph.D.

Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan

Won-Seog Kim, MD, PhD1*, Michinori Ogura, MD, PhD2,3, Toshiki Uchida, MD, PhD3*, Naokuni Uike, M.D., Ph.D.4,5*, Yasunobu Abe, MD, PhD5*, Kenichi Ishizawa, M.D., Ph.D.6,7*, Yoko Okitsu, MD, PhD6*, Kensei Tobinai, MD, PhD8, Fumiko Nagahama9*, Yusuke Sonehara9* and Hirokazu Nagai, MD, PhD10

1Department of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea
2Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan
3Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
4Department of Pallitive Care, Saga-ken Medical Center Koseikan, Saga, Japan
5Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
6Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan
7Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan
8National Cancer Center Hospital, Tokyo, Japan
9Development Division, Solasia Pharma K.K., Tokyo, Japan
10Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Tomohiro Kadota, MD1,2*, Sachiko Seo, MD, Ph.D.2, Yoshihiro Nakagami, MD3*, Hiroe Fuse, MD4*, Yujiro Ueda, MD2*, Genichiro Ishii, MD, Ph.D.5*, Kuniaki Itoh, MD2*, Tomonori Yano, MD1*, Kazuhiro Kaneko, MD, Ph.D1* and Kunihiro Tsukasaki, M.D., Ph.D.2

1Department of Gastroenterology, Endoscopy Division, National Cancer Center Hospital East, Chiba, Japan
2Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan
3Department of Diagnostic Radiology, National Cancer Center Hospital East, Chiba, Japan
4Department of Hematology, Matsudo city hospital, CHIBA, Japan
5Department of Pathology, National Cancer Center Hospital East, Chiba, Japan

Barbara Botto1*, Federica Cavallo2*, Manuela Zanni3*, Antonella Anastasia4*, Chiara Rusconi5*, Annalisa Chiarenza6*, Angela Ferrari7*, Sara Rattotti8*, Alessandra Dondi9*, Marco Calabrese10*, Andrea Evangelista11*, Umberto Vitolo1, Massimo Federico9 and Giuseppe Rossi, MD12

1SC Ematologia, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
2Hematology Division, Department of Molecular Biothecnologies and Health Sciences, Torino, Italy
3Department of Translation Medicine- Amedeo Avogadro University of Eastern Piedmont, Hematology Division, Novara, Italy
4Hematology, Spedali Civili, Brescia, Italy
5Division of Hematology, Niguarda Ca' Granda Hospital, Milano, Italy
6Hematology Section, Department of Clinical and Molecular Biomedicine (MEDBIO), Catania, Italy
7Hematology Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
8Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Oncologia Medica, Università di Modena e Reggio Emilia, Modena, Italy
10Fondazione Italiana Linfomi Onlus, Alessandria, Italy
11Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
12Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

Jonathon B. Cohen, MD1, Xuesong Han2*, Xin Hu3*, Ahmedin Jemal2*, Elizabeth Ward2* and Christopher Flowers, MD4

1Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
2American Cancer Society, Atlanta, GA
3Rollins School of Public Health, Emory University, Atlanta, GA
4Winship Cancer Institute of Emory University, Atlanta, GA

Yuankai Shi, MD, PhD1*, Bo Jia1*, Xiaohui He, MD1*, Youwu Shi1*, Mei Dong, MD1*, Jianliang Yang, MD1*, Liqiang Zhou, MD1*, Shengyu Zhou, MD2*, Peng Liu, MD2*, Yan Qin, MD2*, Sheng Yang, MD2*, Hua Lin, MD3*, Lin Gui, MD2*, Changgong Zhang, MD2*, Lin Wang, MD1*, Shanshan Chen, MD1*, Puyuan Xing, MD1*, Hongnan Mo, MD1* and Mingzhe Han, M.D.4

1Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
2Department of Medical Oncology, Cancer Hospital and Institute,Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
3Department of Medical Record Library, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
4Chinese Academy of Medical Sciences, Institute of Hematology, Tianjin, China

Sarit Assouline1*, Michael Crump, MD2, Torsten Holm Nielsen1*, Miguel Alcaide, B. Sc., Ph. D.3*, David Macdonald, MD, FRCPC4, Axel Tosikyan5, Tina Haliotis1*, Celia Greenwood1*, Kathleen Klein Oros6*, Ryan Morin, PhD3*, Nathalie Johnson, MD, PhD7 and Koren Kathleen Mann, PhD1

1McGill University, Montreal, QC, Canada
2Princess Margaret Hospital, Toronto, ON, Canada
3Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
4QEII Health Sciences Centre, Halifax, NS, Canada
5Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada
6McGIll University, Montreal, QC, Canada
7Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada

Mitchell D.B. Hodgins, MD, FRCPC1, Joy Mangel, MD, FRCPC2, Gwynivere Davies, MD, FRCPC3, Leonard A. Minuk, MD, FRCPC4 and Selay Lam, BSc, MD, FRCPC5

1University of Western Ontario, London, ON, Canada
2London Health Sciences Centre, London, ON, Canada
3University of Calgary In Canada, Calgary, AB, Canada
4London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada
5University of Western Ontario, London Health Sciences Centre, London, ON, Canada

Marta García-Recio, MD1*, Antonio Gutierrez, MD, PhD2, Antonia Obrador-Hervia, PhD3*, Lucia García Mañó, MD2*, Leyre Bento, MD1*, Juan Besalduch, MD, PhD1, Jose Rodriguez, MD, PhD4*, Antonia Sampol2*, Priam Villalonga, PhD3* and Silvia Fernandez, PhD3*

1Hospital Son Espases, Palma de Mallorca, Spain
2Hematology, Hospital Son Espases, Palma de Mallorca, Spain
3UIB, Hospital Son Espases, Palma de Mallorca, Spain
4Hematology, MD Anderson, Madrid, Spain

Alberto Pineda, MD1*, Juan-Manuel Sancho, MD, PhD1*, Olga Garcia, MD1*, Jordi Esteve, MD, PhD2, Mar Tormo, MD, PhD3, Pilar Martinez, MD4*, Ferran Vall-llovera, MD5*, Rodrigo Martino, MD, PhD6, Pau Montesinos, MD7*, Jose Gonzalez-Campos, MD8*, Juan Bergua9*, María Calbacho, MD10*, Cristina Gil, MD11*, Ana Vicent, MD12*, Antònia Cladera, MD13*, Jesus Hernandez, MD14*, Maria-José Moreno, MD15*, Alfons Serrano, MD16*, Natalia Alonso, MD17*, Raimundo García, MD18*, Pere Barba, MD, PhD19*, Angeles Fernandez, MD20*, Pilar Miralles, MD, PhD21*, Andrés Novo, MD22*, Jose Maria Moraleda, MD, PhD23*, José Ángel Hernández, MD24*, Eugenia Abella, MD, PhD25*, Magdalena Sanchez, MD26*, Maria-Elsa Lopez, MD27*, Teresa Bernal, MD28*, Mª Carmen Mateos, MD29*, Esperanza Lavilla, MD30* and Josep-Maria Ribera, MD, PhD1

1Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
2Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
3Hospital Clínico Universitario de Valencia, Valencia, Spain
4Hospital Universitario Doce de Octubre, Madrid, Spain
5Hospital Universitari Mutua Terrassa, Terrassa, Spain
6Hospital Santa Creu i Sant Pau, Barcelona, Spain
7Hematology, Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain
8Hospital Universitario Virgen del Rocío, Sevilla, Spain
9Hospital San Pedro de Alcántara, Cáceres, Spain
10Hospital Universitario Ramon y Cajal, Madrid, Spain
11Hospital General de Alicante, Alicante, Spain
12ICO-Hospital Joan XXIII, Tarragona, Spain
13Hospital Son Llàtzer, Palma de Mallorca, Spain
14Hospital Universitario de Salamanca, Salamanca, Spain
15Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
16Hospital Madrid Sanchinarro, Madrid, Spain
17Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
18Hospital General Universitario de Castellón, Castellón, Spain
19Department of Hematology, Hospital Vall d'Hebron, Barcelona, Spain
20Hospital Xeral Cíes, Vigo, Spain
21Hospital Gregorio Marañón, Madrid, Spain
22Hospital Son Espases, Palma de Mallorca, Spain
23Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
24Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain
25Hospital del Mar, Barcelona, Spain
26Hospital General Universitario, Valencia, Valencia, Spain
27Hospital Clínico Universitario Ourense, Ourense, Spain
28Hospital Universitario Central de Asturias, Oviedo, Spain
29Hospital Virgen del Camino, Pamplona, Spain
30Hospital Lucus Augusti, Lugo, Spain

*signifies non-member of ASH